Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Hepatopulmonary syndrome and portopulmonary hypertension

Gastroenterology and hepatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Syncope, resting hypoxaemia, rapidly increasing oxygen requirement, chest pain, haemoptysis or signs of right-heart failure require urgent assessment. Give oxygen for significant hypoxaemia, evaluate common acute cardiopulmonary causes and contact hepatology, respiratory or the designated pulmonary-hypertension centre early. Severe uncontrolled portopulmonary hypertension can make liver transplantation immediately hazardous, whereas severe hepatopulmonary syndrome may increase its urgency; neither diagnosis should be inferred from breathlessness alone.

Synopsis

Distinguish two pulmonary vascular complications of portal hypertension, confirm each with the right test, and coordinate cardiopulmonary optimisation with liver-transplant decisions.

  • Hepatopulmonary syndrome combines liver disease or portal hypertension, intrapulmonary vascular dilatation and an objectively demonstrated oxygenation defect.
  • Platypnoea and orthodeoxia favour hepatopulmonary syndrome because upright posture increases blood flow through basal dilated pulmonary vessels.
  • Agitated-saline contrast appearing in the left heart after a delayed passage supports intrapulmonary shunting; immediate passage suggests an intracardiac communication.
  • Portopulmonary hypertension is pulmonary arterial hypertension associated with portal hypertension and requires right-heart catheterisation for haemodynamic confirmation.
  • Echocardiography is a screening and right-heart assessment tool; it cannot by itself distinguish precapillary disease from high-output or volume-overloaded states.
  • Supplemental oxygen supports hypoxaemic hepatopulmonary syndrome, but liver transplantation is the only established treatment capable of reversing the underlying vascular syndrome.
  • Portopulmonary hypertension treatment belongs in a designated pulmonary-hypertension service because drug selection, hepatic metabolism and transplant thresholds are tightly linked.
  • Both conditions can occur without a direct relationship to conventional liver-test severity, so persistent unexplained dyspnoea deserves purposeful investigation.

Key red flags

Pulmonary hypertension symptoms

Exertional dyspnoea, chest pressure, presyncope or syncope, ankle swelling and declining exercise capacity suggest right-ventricular stress and require specialist investigation.

Acute decompensation warning

Sudden hypoxaemia, pleuritic pain or rapid right-heart deterioration is not a routine evolution of either syndrome; investigate pulmonary embolism, infection, fluid overload and bleeding urgently.

Investigation priorities

01
Pulse oximetry supine and uprightFirst step

Screen for hypoxaemia and document a clinically relevant postural change.

Management branches

HPSConfirm oxygenation and shunt

A person with liver disease or portal hypertension has unexplained dyspnoea, low saturation or orthodeoxia.

  1. Measure saturation with posture, obtain a properly documented room-air arterial blood gas where safe, and investigate common lung, cardiac, anaemic and thromboembolic explanations in parallel.
  2. Arrange agitated-saline contrast echocardiography through an experienced service, interpreting delayed left-sided bubbles as evidence of intrapulmonary vascular passage in the correct clinical context.
  3. Provide oxygen when clinically indicated and refer early to the liver-transplant team because disease-modifying therapy, severity classification and selection exceptions require specialist assessment.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NHSBT organ transplantation policies and guidanceCurrent NHSBT Liver Selection Policy and allocation documents governing specialist transplant decisions.
  • NHS England targeted pulmonary-hypertension therapies policyUpdated specialist commissioning framework for diagnosis, risk assessment and targeted treatment in adults.
  • BTS clinical statement on pulmonary arteriovenous malformationsUK specialty guidance explaining pulmonary right-to-left shunts, contrast echocardiography and hypoxaemia assessment.
  • NHSBT liver transplant waiting and assessment informationNHSBT information on transplant-list assessment, changing severity and the need for individualised risk communication.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draft
Clinical stateAwaiting review
JurisdictionUnited Kingdom